| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77244e189608a6005fb724da0f7f1945 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10021 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 |
| filingDate |
2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c1263b2bd7190323b5d1755354dbfa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_041300313cb6f9bd5010f2c572a203f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac79b4cdfd148936d6ff830a54c315ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3400f86d2e61e8d98ca12aa61f55d177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb26201ffd82bf85c6230b5852a05280 |
| publicationDate |
2017-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106906186-A |
| titleOfInvention |
A multi-epitope vaccine candidate for simultaneous protection against human adenovirus type 3-human adenovirus type 55-human adenovirus type 7 |
| abstract |
The invention relates to the technical field of recombinant virus genetic engineering, in particular to a multi-epitope vaccine candidate strain for simultaneous prevention of human adenovirus type 3, human adenovirus type 55, and human adenovirus type 7, which can be expressed in human adenovirus type 3 hexon Human adenovirus type 55 neutralizing epitope 55R2 and human adenovirus type 7 neutralizing epitope 7R5 were inserted into the HVR2 region and HVR5 region of the human adenovirus type 7 respectively. Virus immune response, the vaccine candidate strain can be used to prepare a trivalent vaccine for preventing human type 3, type 7, and type 55 adenoviruses. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109402066-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109402066-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108514635-A |
| priorityDate |
2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |